|Min SIP Amount||₹500|
|NAV||₹9.61 (18 Sep 2019)|
|Fund Started||13 Jul 2018|
|Fund Size||₹1,331 Cr|
|Sun Pharmaceutical Inds. Ltd.||Healthcare||Equity||10.2%|
|Dr. Reddy's Laboratories Ltd.||Healthcare||Equity||7.3%|
|Cadila Healthcare Ltd.||Healthcare||Equity||5.6%|
|Sanofi India Ltd.||Healthcare||Equity||4.8%|
|SBI Life Insurance Company Ltd.||Financial||Equity||4.7%|
|Torrent Pharmaceuticals Ltd.||Healthcare||Equity||4.2%|
|Ipca Laboratories Ltd.||Healthcare||Equity||4.0%|
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Growth is a Equity Mutual Fund Scheme launched by ICICI Prudential Mutual Fund. This scheme was introduced to investors on 13 Jul 2018. Ihab Dalwai, Priyanka Khandelwal is the Current Fund Manager of ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Growth.The fund currently has an Asset Under Management(AUM) of ₹1,331 Cr and the Latest NAV as of 18 Sep 2019 is ₹9.61.
The ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Growth is rated High risk. Minimum SIP Investment is 500. Minimum Lumpsum Investment is 5000. Exit load of 1% if redeemed within 15 days..
1st Floor, Proms Complex, SBI
Colony, 1A Koramangala, 560034